Skip to main content
. 2021 Aug 17;64(1):71–78. doi: 10.1097/JOM.0000000000002353

TABLE 2.

Cancer Incidence, US Air Force Fighter Aviators (n = 34,976), and Other Officers (n = 316,262), Exposure Period of 1970–2004, Followed Through 2018

Fighter Aviators Other Officers
No. % No. % Crude OR (95% CI) Adjusted OR (95% CI)
Males n = 34,760 n = 274,451
 Colon and rectum 387 1.11 2946 1.07 1.04 (0.93–1.15) 1.00 (0.89–1.12)
 Pancreas 169 0.49 1316 0.47 1.01 (0.86–1.19) 0.94 (0.76–1.11)
 Melanoma skin 416 1.20 2375 0.87 1.39 (1.25–1.54) 1.24 (1.11–1.38)
 Prostate 2124 6.11 12,637 4.60 1.35 (1.29–1.41) 1.23 (1.17–1.30)
 Testis 43 0.12 244 0.09 1.39 (1.01–1.93) 1.29 (1.15–2.12)
 Urinary bladder 305 0.88 2204 0.80 1.09 (0.97–1.23) 1.04 (0.92–1.18)
 Kidney and renal pelvis 78 0.22 657 0.24 0.94 (0.74–1.19) 0.87 (0.68–1.12)
 Brain and nervous system 104 0.30 861 0.31 0.95 (0.78–1.17) 0.88 (0.71–1.10)
 Thyroid 72 0.21 463 0.17 1.23 (0.96–1.58) 1.12 (0.86–1.44)
 Non-Hodgkin lymphoma 309 0.89 1963 0.72 1.25 (1.10–1.40) 1.15 (0.99–1.21)
Females n = 216 n = 41,811
 Melanoma skin 1 0.46 121 0.29 1.60 (0.08–8.10) 1.58 (0.35–18.2)
 Thyroid 1 0.46 194 0.46 1.00 (0.05–5.01) 1.18 (0.29–10.5)
 Non-Hodgkin lymphoma 1 0.46 105 0.25 1.85 (0.09–9.36) 1.62 (0.55–37.2)

CI, confidence interval; OR, odds ratio.

Matched on sex, age group at active duty entrance, and age group at incidence censoring.

Adjusted for race and exact age at incidence censoring.